Kestra Private Wealth Services, LLC Recursion Pharmaceuticals, Inc. Transaction History
Kestra Private Wealth Services, LLC
- $7.43 Billion
- Q4 2025
A detailed history of Kestra Private Wealth Services, LLC transactions in Recursion Pharmaceuticals, Inc. stock. As of the latest transaction made, Kestra Private Wealth Services, LLC holds 17,700 shares of RXRX stock, worth $73,278. This represents 0.0% of its overall portfolio holdings.
Number of Shares
17,700Holding current value
$73,278% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding RXRX
# of Institutions
355Shares Held
305MCall Options Held
7.56MPut Options Held
4.85M-
Vanguard Group Inc Valley Forge, PA47.2MShares$195 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl33.5MShares$139 Million1.15% of portfolio
-
Baillie Gifford & CO23.8MShares$98.4 Million0.09% of portfolio
-
State Street Corp Boston, MA18.3MShares$75.6 Million0.0% of portfolio
-
Black Rock Inc. New York, NY17.3MShares$71.7 Million0.0% of portfolio
About RECURSION PHARMACEUTICALS, INC.
- Ticker RXRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 180,480,000
- Market Cap $747M
- Description
- Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...